AlphaPepe’s Stage 21 Opens Without a Public Trading History
AlphaPepe presale Stage 21 is live after a reported $2.82 million raise, but buyers face unverified traction and no public trading history.
Ethereum’s price-prediction chatter has turned aggressive again, with fresh $12,000 targets circulating as ETH regains momentum and staking demand tightens available supply. Against that backdrop, presale project AlphaPepe says its Stage 20 allocation has sold out and Stage 21 is now live, with the announcement citing more than $2.82 million raised and over 12,100 holders, with more than 100 new holders reportedly joining daily. Those figures come from AlphaPepe’s own press release, and the real question for retail buyers is whether earlier presale timing offsets the risk that comes with unverified, self-reported traction.
Stage 21 Opens Before AlphaPepe’s First Public Chart
Staged presales work on a simple mechanic: each stage sells a fixed token allocation at a set price, and once that allocation clears, the next stage opens at a higher price. That is what turns a stage sellout into a marketing hook, since the price on offer today is, by design, the cheapest one remaining before any exchange listing sets an open-market rate.
According to the announcement, Stage 20 is gone and Stage 21 has opened at a listed price of $0.03111 per $ALPE token. The project frames this as an early-timing story: presale closure and the DEX launch are set for Q1 2027, meaning $ALPE has not yet traded on any public exchange and has no price-discovery history behind it.
That distinguishes AlphaPepe’s pitch from an established asset like Ethereum, which has years of open-market trading, liquidity depth and price history behind it. The announcement also points to AlphaSwap Early Access as a working-product layer sitting behind the presale, though the release itself does not detail what that access currently includes. Some presale trackers have published additional detail on AlphaPepe’s product roadmap and disclosed risks, but those details sit outside AlphaPepe’s own confirmed timeline and have not been reconciled against the Q1 2027 launch date cited in this release.
12,100 Holders and the Stage-Sellout Signal
AlphaPepe’s press release reports that the project recently crossed 12,100 holders, with more than 100 new holders joining every day, a base it says keeps expanding while the token remains off public exchanges. Stage 20’s sellout is presented as part of a pattern, with the release stating that previous stages also sold quickly.
That framing turns holder growth and stage sellouts into a scarcity narrative: the buyer base is forming before there is a chart for it to react to. It is worth noting that the raise total, the holder count and the daily sign-up pace are all self-reported by AlphaPepe rather than confirmed against an independent blockchain explorer cited in the announcement, a gap examined further in coverage of AlphaPepe’s presale traction and disclosed risks.
Earlier Presale Timing Versus an Unverified $12,000 Target
The core argument AlphaPepe is making is about sequencing, not fundamentals: buyers entering Stage 21 do so before $ALPE has any DEX chart, meaning there is no trading history to judge against and no way to confirm how the token behaves once it becomes liquid. Each completed stage removes an earlier, cheaper entry point, which is the standard scarcity mechanic presale marketing leans on, but it does not guarantee that Stage 21 buyers will see a better outcome than buyers who wait for the DEX launch to see how the market actually prices the token.
Ethereum, by contrast, is deep into an established public-market cycle, and the renewed $12,000 chatter is tied to a resistance breakout following a late-August rally and to staking data showing more ETH queued to enter staking than to exit. That combination is being used to build the bull case for a much larger move, though a run to $12,000 would require a substantially larger market expansion than ETH has yet delivered, and the figure remains a prediction rather than a confirmed trajectory. Broader long-range forecasting exercises, including AI-generated price predictions for Ethereum, BNB and Solana, show just how wide the range of speculative year-end targets for ETH has become across the market.

AlphaPepe’s pitch essentially asks buyers to accept presale-stage risk, an unlisted token with zero trading history, in exchange for entering ahead of a launch timeline the project itself controls. That is a fundamentally different risk profile than buying an asset that already has years of liquidity, custody infrastructure and independent price discovery behind it, and the two should not be weighed on the same scale just because both appear in the same headline.
The Fine Print
AlphaPepe’s figures, the $2.82 million raise, the 12,100 holders, the $0.03111 price and the Stage 20 sellout, come from a press release the project supplied to GlobeNewswire, which explicitly states it has not verified or endorsed the claims made in it. The $12,000 Ethereum figure is likewise a prediction, not a guarantee, and presale tokens carry the risk of total capital loss with no established secondary market to exit through until a listing actually happens. None of this constitutes financial advice, and independent research plus a qualified financial advisor remain the standard next step before committing capital to an unlisted token.
Follow CoinNews on X and Telegram for ongoing coverage of presale launches and Ethereum’s price trajectory.